 Contributed by Parmjeet Randhawa, M.D.
 Contributed by Parmjeet Randhawa, M.D.
Tubular & myocyte vacuolization is a morphologic criterion for drug toxicity, provided other ischemic & metabolic insults have been reasonably excluded.
Calcification in the allograft kidney is generally of the dystrophic type, and reflects prior injury due to ischemia, drug toxicity or rejection. A small proportion of cases result from hyperparathyroidism occurring secondarily to end-stage renal disease in the native kidney. Correlation with the clinical findings and serum biochemistry is suggested.
This biopsy also contains a minimal interstitial infiltrate which does not qualify for the diagnosis of acute rejection. However, the sample contains only 7 glomeruli, and 1 artery, and falls short of the Banff criteria for specimen adequacy. If the patient' s clinical status continues to deteriorate, a repeat sample may be helpful.
Previous Biopsies on this Patient:
None
TPIS Related Resources:
Kidney Transplant Topics
 
 
 
 
 
 
(2 H&E, 1 PAS)
1.   Glomerulosclerosis
     1.1  Number of glomeruli . . . . .(7 )
     1.2  Number globally sclerotic . .(0 )
     1.3  Segmental sclerosis . . . . .( )YES(x )NO
2. Glomerulitis(g). . . . . . . . . .(x )0 ( )1 ( )2 ( )3
3.   Interstitial inflammation(i) . . .(x )0  (x )1  ( )2  ( )3
     (check if present) . . . . . . .( )Neutrophils( )Eosinophils
4.   Intimal arteritis(v) . . . . . . .(x )0  ( )1  ( )2  ( )3 
                                         ( )Not evaluable
5.   Tubulitis(t) . . . . . . . . . . .(x )0  (x )1  ( )2  ( )3
6.   Arteriolar hyalin(ah). . . . . . .(x )0  ( )1  ( )2  ( )3
                                         ( )Not evaluable
     Nodular form . . . . . . . . . . .( )YES( )NO
7.   Chronic glomerular change(cg). . .(x )0  ( )1  ( )2  ( )3
7b.  Mesangial matrix increase (mm) . .(x)0  ( )1  ( )2  ( )3
8. Interstitial fibrosis(ci). . . . .(x )0 ( )1 ( )2 ( )3
9. Tubular atrophy(ct). . . . . . . .(x )0 ( )1 ( )2 ( )3
10.  Vascular intimal sclerosis(cv) . .(x )0  ( )1  ( )2  ( )3
                                         ( )Not evaluable
10b. Number of arteries with internal elastic lamina: (1 )
11. Other findings:
12.  Diagnostic categories (Check as many categories as appropriate) 
( )KDARO:  Normal   
( )KDAB:  Antibody mediated rejection 
( )KDARB:  Borderline change (i0-2, t0-2, v0)
( )  Acute rejection (specify g, i, t, v grades):
 ( )KDAR1A:  Banff Type 1A (i1-3, t2, v0)
 ( )KDAR1B:  Banff Type 1B (i2-3, t3, v0)
 ( )KDAR2A:  Banff Type IIA (i1-3, t0-3, v1)
 ( )KDAR2B:  Type 2B (i1-3, t0-3, v2)
 ( )KDAR3:    Type III (i1-3, t0-3, v3)    
( )  Chronic allograft nephropathy (Specify cg, ci, ct, cv grades):
 ( )KDCR1a:  Mild, without specific changes suggesting chronic rejection    
 ( )KDCR1b:  Mild, with specific changes suggesting chronic rejection  
 ( )KDCR2a:  Moderate, without specific changes suggesting chronic rejection
 ( )KDCR2b:  Moderate, with specific changes suggesting chronic rejection
 ( )KDCR3a:  Severe, without specific changes suggesting chronic rejection
 ( )KDCR3b:  Severe, with specific changes suggesting chronic rejection
(x )  KDDR: Tubular and/or myocyte vacuolization c/w drug-associated changes.
(x )  KDAT: Acute tubular necrosis.
( )  KDDO: Donor disease.
Other:
( )  Recurrent disease (specify)
( )  Subcapsular injury       ( )Pyelonephritis
( )  CMV                      ( )PTLD
( )  Obstruction              ( )Reflux
p
( )  Vascular thrombosis (specify)
(x )  Miscellaneous